We are live on ! Find out more
Lazard Asset Management

Lazard Asset Management Portfolio holdings

AUM $60.8B
1-Year Est. Return 22.47%
This Fund
S&P 500
This Quarter Est. Return
+8.66%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$70B
AUM Growth
+$9.17B
Cap. Flow
+$1.72B
Cap. Flow %
2.45%
Top 10 Hldgs %
24.19%
Holding
1,743
New
270
Increased
557
Reduced
362
Closed
215

Top Sells

Rank Stock Value
1
NTES icon
NetEase
NTES
+$470M
2
KSU
Kansas City Southern
KSU
+$278M
3
ETN icon
Eaton
ETN
+$269M
4
PHI icon
PLDT
PHI
+$195M
5
BUD icon
AB InBev
BUD
+$143M

Sector Composition

Rank Sector Weight
1 Technology 19.33%
2 Healthcare 15.85%
3 Financials 13.41%
4 Industrials 13.3%
5 Communication Services 9.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CASS icon
1326
Cass Information Systems
CASS
$714M
$4K ﹤0.01%
74
-256
-78% -$14.3K
FRHC icon
1327
Freedom Holding
FRHC
$9.63B
$4K ﹤0.01%
+310
New +$4.41K
KTB icon
1328
Kontoor Brands
KTB
$4.63B
$4K ﹤0.01%
112
+10
+10% +$378
PNTG icon
1329
Pennant Group
PNTG
$1.4B
$4K ﹤0.01%
+150
New +$3.43K
ROAD icon
1330
Construction Partners
ROAD
$5.84B
$4K ﹤0.01%
+257
New +$4.51K
CDMO
1331
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$4K ﹤0.01%
+600
New +$3.5K
NXGN
1332
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$4K ﹤0.01%
250
+88
+54% +$1.45K
JNCE
1333
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$4K ﹤0.01%
+505
New +$2.73K
INST
1334
DELISTED
Instructure, Inc.
INST
$4K ﹤0.01%
+89
New +$4.17K
AGYS icon
1335
Agilysys
AGYS
$2.97B
$3K ﹤0.01%
+150
New +$3.79K
CHRW icon
1336
C.H. Robinson
CHRW
$17.4B
$3K ﹤0.01%
+51
New +$4.06K
CORT icon
1337
Corcept Therapeutics
CORT
$12.4B
$3K ﹤0.01%
+249
New +$3.47K
EQT icon
1338
EQT Corp
EQT
$33.3B
$3K ﹤0.01%
303
-11,731
-97% -$115K
EVER icon
1339
EverQuote
EVER
$892M
$3K ﹤0.01%
114
FINV
1340
FinVolution Group
FINV
$1.15B
$3K ﹤0.01%
1,335
-9,400
-88% -$24.9K
LE icon
1341
Lands' End
LE
$370M
$3K ﹤0.01%
+195
New +$2.55K
ONTO icon
1342
Onto Innovation
ONTO
$12.9B
$3K ﹤0.01%
108
PAM icon
1343
Pampa Energía
PAM
$4.75B
$3K ﹤0.01%
197
RCI icon
1344
Rogers Communications
RCI
$18.3B
$3K ﹤0.01%
67
-357
-84% -$17.2K
SAM icon
1345
Boston Beer
SAM
$1.91B
$3K ﹤0.01%
9
SRPT icon
1346
Sarepta Therapeutics
SRPT
$1.57B
$3K ﹤0.01%
24
-150
-86% -$15.1K
TRIP icon
1347
TripAdvisor
TRIP
$1.65B
$3K ﹤0.01%
131
-262
-67% -$8.82K
ZBH icon
1348
Zimmer Biomet
ZBH
$18.2B
$3K ﹤0.01%
+22
New +$3.04K
TREC
1349
DELISTED
Trecora Resources
TREC
$3K ﹤0.01%
493
AMED
1350
DELISTED
Amedisys
AMED
$2K ﹤0.01%
12
-168
-93% -$25K

Similar funds

Lazard Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, Lazard Asset Management held 1,743 positions worth $70B, up 15% from $60.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Lazard Asset Management's Q4 2019 filing shows 270 new, 557 increased, 362 reduced and 215 closed positions. Its largest new stake was West Pharmaceutical: 89,164 shares worth $13.4M. The largest sale was NetEase, an estimated $470M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • Lazard Asset Management's largest Q4 2019 buy was West Pharmaceutical: 89,164 shares worth $13.4M.
  • Lazard Asset Management added most to McDonald's in Q4 2019, an estimated $575M increase.
  • Lazard Asset Management's biggest Q4 2019 reduction was NetEase, cutting an estimated $470M.
  • Lazard Asset Management fully exited Corelogic, Inc. in Q4 2019, selling an estimated $68.4M.
  • Lazard Asset Management's ten largest holdings make up 24% of its $70B portfolio in Q4 2019.
  • Lazard Asset Management opened 270 new positions and closed 215 in Q4 2019.
  • Lazard Asset Management's portfolio value rose 15% quarter-over-quarter to $70B.

Based on Lazard Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.